Intero Biosystems wants drugmakers to test on mini human intestines, not animals
Summary
Intero Biosystems is offering pharmaceutical companies laboratory-grown human intestines as an alternative to animal testing. The startup aims to scale its production capacity and further develop its organoid technology to meet the rising demand from regulators.
Intero Biosystems is selling lab-grown human intestines to drugmakers as regulators push for alternatives to animal testing, while the startup looks to scale production and expand its organoid technology.
Source: Read the full story at TechCrunch
Disclaimer: This content is for informational and educational purposes only and is not financial, investment or trading advice. Tech & Money Press is not a registered investment adviser or broker-dealer. Trading stocks, options and crypto involves substantial risk, including the loss of your entire investment. Do your own research and consult a licensed professional before making any financial decision. The authors may hold positions in the securities mentioned. News summaries are written with AI assistance from the original publisher's report and may contain errors; always check the original source. Full disclaimer.